Although autoimmune diseases are rare, they affect 14.7 to 23.5 million people in the world. Currently, cures are not yet available for most autoimmune diseases and patients face a lifetime of illness and treatment. Hence, it is necessary to develop effective drugs for the treatment of autoimmune disease. Creative Biolabs is focused on developing novel therapies for autoimmune diseases by harnessing our extensive expertise and well-established drug development technologies. Our featured services include monoclonal antibody development, bispecific antibody development, and cell-based therapy development. We are committed to becoming your best partner to develop novel and effective drugs for autoimmune diseases.
Autoimmune diseases develop when underlying defects in the immune system lead the body to attack its organs, tissues, and cells. Common autoimmune diseases include rheumatoid arthritis (RA), inflammatory bowel disease (IBD), type 1 diabetes, multiple sclerosis (MS), and systemic lupus erythematosus (SLE). More than 23.5 million people in the U.S. suffer from autoimmune diseases. Now there is no cure for autoimmune diseases. Common treatments including immunosuppressive agents and anti-inflammatory drugs aim to relieve symptoms like pain, swelling, fatigue, and skin rashes. Moreover, these treatments are expensive and come with side effects. Therefore, it is necessary to develop effective, safe, and low-cost drugs for the treatment of autoimmune diseases. At present, many novel therapeutic strategies are being investigated including monoclonal antibodies, fusion proteins, molecular mimics, cell therapy, gene therapy, and antigen-specific immunotherapy. These therapies aim to suppress the harmful effects of hyperactivity immune responses while maintaining the immune system's ability to fight non-self antigens.
Creative Biolabs has assembled a team of world-class leaders who are skilled in exploring and identifying novel therapeutics for autoimmune disease. Supported by the experienced leadership team and powerful technical platforms, we provide a full range of therapeutic antibody development and cell therapy development services for global clients. If you are studying novel drugs for treating autoimmune diseases, please don't hesitate to contact us to discuss your project. We are thrilled to become your reliable partner to develop novel therapies for autoimmune diseases.
For Research Use Only | Not For Clinical Use